Somatic CHEK2 mutations have been identified as putative CLL drivers, while CHEK2 germline variants have recently been indicated as a novel predisposition gene in CLL, implying that CLL may belong to the spectrum of malignancies associated with germline variant in CHEK2 (54). The gene discussed is CHEK2; the disease is B-cell chronic lymphocytic leukemia.